Sign In
Buy CLRB
$2.60
-0.140 (-5.11%)
At Close: Jun 03, 2026
Cellectar Receives Orphan Drug Designation from the European Commission for CLR 131 in Waldenstrom's Macroglobulinemia
08:30am, Wednesday, 27'th Jan 2021
Benefits include 10 years of market exclusivity in the European Union Benefits include 10 years of market exclusivity in the European Union
FLORHAM PARK, N.J., Dec. 28, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercializ
Cellectar Biosciences Announces Pricing of $24.5 Million Underwritten Public Offering and $20.5 Million Concurrent Private Placement
08:39am, Wednesday, 23'rd Dec 2020
FLORHAM PARK, N.J., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercializ
Cellectar Biosciences Announces Proposed Underwritten Public Offering and Concurrent Private Placement
05:28pm, Tuesday, 22'nd Dec 2020
FLORHAM PARK, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercializ
Is Cellectar Biosciences (CLRB) A Good Stock To Buy According To Hedge Funds?
04:13pm, Friday, 27'th Nov 2020
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September. At Inside
Cellectar Reports Third Quarter 2020 Financial Results and Provides a Corporate Update
08:44am, Monday, 09'th Nov 2020
FLORHAM PARK, N.J., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commerciali
Q3 2020 EPS Estimates for PDC Energy, Inc. Lowered by Capital One Financial (NASDAQ:PDCE)
01:08am, Friday, 23'rd Oct 2020
PDC Energy, Inc. (NASDAQ:PDCE) – Equities research analysts at Capital One Financial dropped their Q3 2020 EPS estimates for PDC Energy in a research report issued on Tuesday, October 20th. Capital
Mangrove isn’t simply a ‘black story’, but central to our country’s history | Kenan Mailk
07:15am, Sunday, 11'th Oct 2020
Steve McQueen’s new film is part of a renewed interest in ‘history from below’
PDC Energy Announces Third Quarter 2020 Conference Call – Thursday, November 5, 2020
03:15pm, Wednesday, 07'th Oct 2020
PDC Energy, Inc. (“PDC” or the “Company”) (Nasdaq:PDCE) today announced plans to host a conference call to discuss third quarter 2020 operating and financial
Charles Schwab Investment Management Inc. Boosts Stock Position in PDC Energy, Inc. (NASDAQ:PDCE)
07:22am, Sunday, 04'th Oct 2020
Charles Schwab Investment Management Inc. grew its stake in PDC Energy, Inc. (NASDAQ:PDCE) by 6.2% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commi
PDC Energy Target of Unusually Large Options Trading (NASDAQ:PDCE)
07:00am, Wednesday, 16'th Sep 2020
PDC Energy Inc (NASDAQ:PDCE) was the target of unusually large options trading activity on Tuesday. Traders purchased 2,021 put options on the company. This is an increase of 712% compared to the aver
Cellectar Biosciences Phase 2 Data In Multiple Myeloma Is Worth A Look
01:40pm, Monday, 14'th Sep 2020
CLRB's CLR131 recorded a 40% ORR in a Phase 2 Multiple Myeloma study (granted 6 of 15 patients). KPTI's Xpovio was approved for Multiple Myeloma with a lower ORR.
Intra-Cellular Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma
03:14am, Saturday, 12'th Sep 2020
Intra-Cellular stock jumps as its bipolar trial delivers positive data. Medtronic moves ahead with heart valve disease trial.
PDC Energy Announces Pricing of $150 Million Tack-On Senior Notes Offering
10:30pm, Thursday, 10'th Sep 2020
DENVER, Sep 10, 2020 (GLOBE NEWSWIRE via COMTEX) --
DENVER, Sept. 10, 2020 (GLOBE NEWSWIRE) -- PDC Energy, Inc. ("PDC" or the "Company") (Nasdaq:PDCE) today...
PDC Energy Announces Pricing of $150 Million Tack-On Senior Notes Offering
10:30pm, Thursday, 10'th Sep 2020
PDC Energy, Inc. ("PDC" or the "Company") (Nasdaq:PDCE) today announced that it has priced its previously announced public offering of an additional $150
